595
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model

, , , , , , , , , , , , , , , , & show all
Pages 33-43 | Received 25 Jan 2013, Accepted 04 Jun 2013, Published online: 17 Jul 2013

References

  • Andersson-Willman B, Gehrmann U, Cansu Z, Buerki-Thurnherr T, Krug HF, Gabrielsson S, et al. 2012. Effects of subtoxic concentrations of TiO2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol Appl Pharmacol 264(1):94–103
  • Angelis JK, Dusinska M, Collins AR. 1999. Single cell gel electrophoresis: detection of DNA damage at different levels of sensitivity. Electrophoresis 20:2133–2138
  • Bartneck M, Keul HA, Wambach M, Bornemann J, Gbureck U, Chatain N, et al. 2012. Effects of nanoparticle surface-coupled peptides, functional endgroups, and charge on intracellular distribution and functionality of human primary reticuloendothelial cells. Nanomedicine 8(8):1282–1292
  • Basarkar A, Devineni D, Palaniappan R, Singh J. 2007. Preparation, characterization, cytotoxicity and transfection efficiency of poly(dl-lactide-co-glycolide) and poly(dl-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm 343:247–254
  • Collins AR, Dusinska M, Gedik CM, Stetina R. 1996. Oxidative damage to DNA: we have a reliable biomarker? Environ Health Perspect 104:465–469
  • De Lima R, do Espirito Santo Pereira A, Porto RM, Fraceto LF. 2011. Evaluation of cyto- and genotoxicity of poly(lactide-co-glycolide) nanoparticles. J Polym Environ 19:196–202
  • Duan Y, Liu J, Ma L, Li N, Liu H, Wang J, et al. 2010. Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials 31(5):894–899
  • Dusinska M; NanoTEST consortium. 2009. Testing strategies for the safety of nanoparticles used in medical application. Nanomedicine editorial 4:605–607
  • Dusinska M, Collins AR. 1996. Detection of oxidised purines and UV-induced photoproducts in DNA, by inclusion of lesion-specific enzymes in the comet assay (single cell gel electrophoresis). ATLA 24:405–411
  • Dusinska M, Collins AR. 2008. The comet assay in human biomonitoring: gene–environment interactions. Mutagenesis 23:191–205
  • Elhajouji M, Cunha M, Kirsch Volders M. 1998. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis 13:193–198
  • Eyles JE, Bramwell VW, Singh J, Williamson ED, Alpar HO. 2003. Stimulation of spleen cells in vitro by nanospheric particles containing antigen. J Control Release 86:25–32
  • Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084–1104
  • Ghoneum M, Ghoneum A, Gimzewski J. 2010. Nanodiamond and nanoplatinum liquid, DPV576, activates human monocyte-derived dendritic cells in vitro. Anticancer Res 30(10):4075–4079
  • Gonzalez L, Thomassen LCJ, Plas G, Rabolli V, Napierska D, Decordier I, et al. 2010. Exploring the aneugenic and clastogenic potential in the nanosize range: A549 human lung carcinoma cells and amorphous monodisperse silica nanoparticles as models. Nanotoxicology 4:382–395
  • Gustafsson Å, Lindstedt E, Elfsmark LS, Bucht A. 2011. Lung exposure of titanium dioxide nanoparticles induces innate immune activation and long-lasting lymphocyte response in the Dark Agouti rat. J Immunotoxicol 8(2):111–121
  • Hamdy S, Haddadi A, Hung RW, Lavasanifar A. 2011. Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. Adv Drug Deliv Rev 63(10-11):943–955
  • He L, Yang L, Zhang Z, Gong T, Deng L, Gu Z, et al. 2009. In vitro evaluation of the genotoxicity of a family of novel MeO-PEG-poly(D,L-lactic-co-glycolic acid)-PEG-OMe triblock copolymer and PLGA nanoparticles. Nanotechnology 20:1–8
  • Hulikova K, Benson V, Svoboda J, Sima P, Fiserova A. 2009. N-Acetyl-D-glucosamine-coated polyamidoamine dendrimer modulates antibody formation via natural killer cell activation. Int Immunopharmacol 9(6):792–799
  • HUMN – HUman MicroNucelus. International Collaborative Project on Micronucleus Frequency in Human Populations. http://www.humn.org
  • Hussain S, Al-Nsour F, Rice AB, Marshburn J, Ji Z, Zink JI, et al. 2012. Cerium dioxide nanoparticles do not modulate the lipopolysaccharide-induced inflammatory response in human monocytes. Int J Nanomedicine 7:1387–1397
  • Hussain S, Garantziotis S. 2013. Interplay between apoptotic and autophagy pathways after exposure to cerium dioxide nanoparticles in human monocytes. Autophagy 9(1):101–103
  • Karlsson HL. 2010. The comet assay in nanotoxicology research. Anal Bioanal 398:651–666
  • Kazimirova A, Magdolenova Z, Barancokova M, Staruchova M, Volkovova K, Dusinska M. 2012. Genotoxicity testing of PLGA-PEO nanoparticles in TK6 cells by the comet assay and the cytokinesis-block micronucleus assay. Mutat Res 748(1-2):42–47
  • Keijzer C, Slütter B, van der Zee R, Jiskoot W, van Eden W, Broere F. 2011. PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity. PLoS One 6(11):e26684
  • Kirsch-Volders M, Plas G, Elhajouji A, Lukamowicz M, Gonzalez L, Vande Loock K, et al. 2011. The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch Toxicol 85:873–899
  • Lankveld DP, Van Loveren H, Baken KA, Vandebriel RJ. 2010. In vitro testing for direct immunotoxicity: state of the art. Methods Mol Biol 598:401–423
  • Lord MS, Jung M, Teoh WY, Gunawan C, Vassie JA, Amal R, et al. 2012. Cellular uptake and reactive oxygen species modulation of cerium oxide nanoparticles in human monocyte cell line U937. Biomaterials 33(31):7915–7924
  • Magdolenova Z, Lorenzo Y, Collins A, Dusinska M. 2012. Can standard genotoxicity tests be applied to nanoparticles? J Toxicol Environ Health A 75(13-15):800–806
  • Mahapatro A, Singh DK. 2011. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol 9:55
  • Mieszawska AJ, Gianella A, Cormode DP, Zhao Y, Meijerink A, Langer R, et al. 2012. Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging. Chem Commun (Camb) 48(47):5835–5837
  • Moon EY, Yi GH, Kang JS, Lim JS, Kim HM, Pyo S. 2011. An increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticles. J Immunotoxicol 8(1):56–67
  • Napierska D, Quarck R, Thomassen LC, Lison D, Martens JA, Delcroix M, et al. 2012. Amorphous Silica Nanoparticles Promote Monocyte Adhesion to Human Endothelial Cells: Size-Dependent Effect. Small Oct 8
  • Nicolete R, dos Santos DF, Faccioli LH. 2011. The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. Int Immunopharmacol 11:1557–1563
  • OECD Guideline for testing of Chemicals. No 429: Skin Sensitization: Local Lymph Node Assay, 2010
  • OECD Guideline for testing of Chemicals. No 487: In Vitro Mammalian Cell Micronucleus Test, 2010
  • Oostingh GJ, Casals E, Italiani P, Colognato R, Stritzinger R, Ponti J, et al. 2011. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Part Fibre Toxicol 8(1):8
  • Pan X, Chen L, Liu S, Yang X, Gao JX, Lee RJ. 2009. Antitumor activity of G3139 lipid nanoparticles (LNPs). Mol Pharm 1:211–220
  • Park EJ, Park K. 2009. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett 184(1):18–25
  • Prach M, Stone V, Proudfoot L. 2013. Zinc oxide nanoparticles and monocytes: impact of size, charge and solubility on activation status. Toxicol Appl Pharmacol 266(1):19–26
  • Rosefort C, Fauth E, Zankl H. 2004. Micronuclei induced by aneugens and clastogens in mononucleate and binucleate cells using the cytokinesis block assay. Mutagenesis 19:277–284
  • Segat D, Tavano R, Donini M, Selvestrel F, Rio-Echevarria I, Rojnik M, et al. 2011. Proinflammatory effects of bare and PEGylated ORMOSIL-, PLGA- and SUV-NPs on monocytes and PMNs and their modulation by f-MLP. Nanomedicine (Lond) 6(6):1027–1046
  • Semete B, Booysen LI, Kalombo L, Venter JD, Katata L, Ramalapa B, et al. 2010. In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles. Toxicol Appl Pharmacol 249(2):158–165
  • Speit G, Schütz P, Bonzheim I, Trenz K, Hoffmann H. 2004. Sensitivity of the FPG protein towards alkylation damage in the comet assay. Toxicol Lett 15:151–158
  • Taira M, Nezu T, Sasaki M, Kimura S, Kagiya T, Harada H, et al. 2009. Gene expression analyses of human macrophage phagocytizing sub-micro titanium particles by allergy DNA chip (Genopal). Biomed Mater Eng 19(1):63–70
  • Thomas C, Rawat A, Hope-Weeks L, Ahsan F. 2011. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine. Mol Pharm 8(2):405–415
  • Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, et al. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221
  • van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, et al. 2012. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6(8):7427–7442
  • Vannucci L, Fiserová A, Sadalapure K, Lindhorst TK, Kuldová M, Rossmann P, et al. 2003. Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo. Int J Oncol 23(2):285–296
  • Wen ZS, Xu YL, Zou XT, Xu ZR. 2011. Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Mar Drugs 9(6):1038–1055
  • Yang CY, Tai MF, Lin CP, Lu CW, Wang JL, Hsiao JK, et al. 2011. Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology. PLoS One 6(9):e25524
  • Yang EJ, Kim S, Kim JS, Choi IH. 2012. Inflammasome formation and IL-1β release by human blood monocytes in response to silver nanoparticles. Biomaterials 33(28):6858–6867

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.